Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—Specialty & Generic Average - - - - - - 364,688.68 33,298.29 1,593.20 78,806.98 -78.41 0.01 22.2683 52.75 0.3352 -0.7781 0.00 0.03 2.4369 - -
Maximum - - - - - - 9,945,147.00 528,312.00 32,061.00 1,988,352.00 12,901.00 0.05 511.0525 2,720.42 0.8371 0.7155 0.08 1.46 35.1990 - -
Minimum - - - - - - 0.00 0.00 -9,633.00 -277,041.00 -18,385.00 0.00 -791.2164 -853.08 -3.9254 -42.3731 -0.31 -0.90 0.0000 - -
Amphastar Pharmaceuticals, Inc. AMPH 47.71 -0.86 -1.77% 340 vs. 346 2,293.00 171.00 43.00 46.00 452.00 0.9000 12.1264 0.0000 0.5080 0.2513 0.0642 0.0274 1.6856 48.00
Alkermes plc ALKS 29.23 -0.85 -2.81% 1,494 vs. 1,674 4,729.00 350.00 36.00 12.00 -1,306.00 0.2200 31.0625 0.0000 0.8256 0.1051 0.0294 0.0173 2.3141 161.00
Neurocrine Biosciences, Inc. NBIX 127.01 -0.16 -0.13% 832 vs. 968 12,859.00 515.00 43.00 119.00 -113.00 0.4300 81.2772 0.0000 0.9752 0.0842 0.0182 0.0125 2.3303 101.00
Intra-Cellular Therapies, Inc. ITCI 88.49 -3.08 -3.36% 791 vs. 537 9,381.00 144.00 -15.00 -34.00 -1,632.00 -0.1600 -108.4422 0.0000 0.9317 -0.1052 -0.0254 -0.0204 4.5143 106.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ITCI and its peers to uncover potential buy and sell opportunities.